^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

TT11

i
Other names: TT11, CD30.CAR-T cell therapy, TT11 CD30 CAR Ts, CD30.CAR-T, ATLCAR.CD30 cell therapy, ATLCAR.CD30 cells, CAR.CD30 T cell therapy, TT-11, TT 11
Company:
Baylor Scott & White Research Institute, Tessa Therap, UNC Lineberger Comprehensive Cancer Center
Drug class:
CD30-targeted CAR-T immunotherapy